All News

Atoltivimab, maftivimab, and odesivimab-ebgn (Inmazeb), a monoclonal antibody cocktail ffor the treatment of adult and pediatric patients with Ebola virus infection, becomes the first drug approved to treat Ebola virus.

The FDA approved an expanded label for for pembrolizumab for adult patients with relapsed or refractory classical Hodgkin lymphoma.

Hospitalized patients with COVID-19 treated with enoxaparin were found to have lower rates of thrombosis, kidney injury, and mortality than patients treated with unfractionated heparin.

Age has been connected to symptom severity and mortality in COVID-19, however, it does not affect susceptibility to infection with the virus.

Although researchers still hope to learn what protection immunoglobulin G antibodies offer against re-infection, this study could have broad implications in the development of a COVID-19 vaccine.

Due to the suboptimal rates of live-attenuated varicella vaccination, outbreaks of varicella-zoster virus still occur, causing incidence of both varicella and herpes zoster.

One in 4 adults reported a change in alcohol use almost immediately after stay-at-home orders were issued during the coronavirus disease 2019 pandemic.

Copanlisib (Aliqopa) in combination with rituximab (Rituxan) prolonged progression-free survival in patients with non-Hodgkin lymphoma who relapsed following 1 or more previous lines of rituximab-based therapy.

The combination of isolating potentially sick patients in their car and conducting the test in a ventilated setting minimizes COVID-19 transmission to the rest of the population.

The physical and emotional stress of a COVID-19 diagnosis might be the triggering factor for the development of herpes zoster ophthalmicus.

Investigators found a link between the sleep quality of mother and child related to the COVID-19 pandemic.

Despite it being fall, sun safety is important all year and even needs to be considered for winter sport activities, such as snowboarding and skiing.

Evidence-based cancer regimens have been shown to result in better outcomes, including longer survival and less toxicity.

Higher rates of mental health symptoms were found among younger respondents, those who identified themselves as female, and those who reported having a pre-existing mental health condition.

Some of these behaviors are not considered indicators of Alzheimer disease or other memory-impairing illnesses.

The importance of a team-based approach including pharmacy staff in performing medication reconciliation during a transition of care for patients being discharged from the hospital.

Pacritinib is a JAK2/FLT3 inhibitor for the treatment of patients with myelofibrosis and severe thrombocytopenia defined as platelet counts of less than 50,000 μL.

The COVID-19 pandemic has caused many routine colorectal cancer screenings to be delayed.

Data from all 50 states and the District of Columbia showed a gradual, steady decline in viral transmission rates during the 8 weeks immediately preceding relaxation of physical distancing rules.

Given the collision of COVID-19 and flu season, receiving the flu vaccine may hold additional benefits by reducing symptoms that may be confused with those of the novel coronavirus.

Those hospitalized for COVID-19 are, on average, younger and healthier than hospitalized flu patients.

By using a positive outlook on these circumstances, pharmacy students can learn many lessons that will set them up for success in the future.

Heart attack, stroke, stent placement, or heart failure hospitalization occurred in 5.3% of the telemonitored group compared with 10.4% of the routine primary care group.

In the absence of a direct head-to-head clinical trial, study may help inform treatment selections for stem cell transplant-ineligible patients.

The research found that obese patients with diabetes were significantly less likely to develop pancreatic cancer if they had undergone bariatric surgery, with the majority of the patients in the study being female.

According to Good Day Pharmacy, plans change each year, and the best plan in 2020 may not be the best plan for 2021.

Enfortumab vedotin-ejfv (Padcev) elicited durable responses in patients with locally advanced or metastatic urothelial cancer who received previous treatment with a PD-1/PD-L1 inhibitor.

KG is a female patient aged 44 years who came to the pharmacy with a prescription that the pharmacist recognized is the treatment regimen for a new blood clot.